Año: 2022
Journal Impact Factor (JIF): 14.20
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 7/96 | Q1 | T1 | D1 |
| MICROBIOLOGY | SCIE | 8/135 | Q1 | T1 | D1 |
Año: 2022
Journal Citation Indicator (JCI): 2,350
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 9/129 | Q1 | T1 | D1 | 93,41 |
| MICROBIOLOGY | 11/156 | Q1 | T1 | D1 | 93,27 |
Año:
2022
CiteScore:
21,500
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 12/304 | Q1 | T1 | D1 |
| Microbiology (medical) | 7/124 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
3,587
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 11/341 | Q1 | T1 | D1 |
| Medicine (miscellaneous) | 53/2531 | Q1 | T1 | D1 |
| Microbiology (medical) | 7/137 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| European Development Regional Fund "A way to achieve Europe," Operative Program Intelligence Growth 2014-2020 | - |
| Innovative Medicines Initiative Joint Undertaking (European Union FP7/2007-2013) | 115523 |
| Innovative Medicines Initiative Joint Undertaking (GlaxoSmithKline Biologicals SA, as EFPIA partner) | 115523 |
| Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades | - |
| Plan Nacional de I + D + i 2013-2016 | - |
| Spanish Network for Research in Infectious Diseases | REIPI RD16/0016/0001; 0002; 0005; 0009; 0011; 0015 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Espindola, Reinaldo | Hospital Universitario Virgen Macarena; Hospital Universitario de Valme (Spain) |
| 2 | Vella, Venanzio | GlaxoSmithKline SpA (Italy) |
| 3 | Benito, Natividad | Universitat Autònoma de Barcelona (Spain) |
| 4 | Mur, Isabel | Universitat Autònoma de Barcelona (Spain) |
| 5 | Tedeschi, Sara | Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola - Malpighi (Italy) |
| 6 | Rossi, Nicolò | Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola - Malpighi (Italy) |
| 7 | Hendriks, Johannes G.E. | Sin datos () |
| 8 | Sorlí, Luisa | Hospital del Mar (Spain) |
| 9 | Murillo, Óscar | Hospital Universitari de Bellvitge (Spain) |
| 10 | Scarborough, Mathew | Oxford University Hospitals NHS Foundation Trust (United Kingdom) |
| 11 | Scarborough, Claire | Oxford University Hospitals NHS Foundation Trust (United Kingdom) |
| 12 | Kluytmans, Jan | Amphia Hospital (Netherlands) |
| 13 | Ferrari, Mateo Carlo | Humanitas Research Hospital (Italy) |
| 14 | Pletz, Mathias W. | Universitätsklinikum Jena und Medizinische Fakultät (Germany) |
| 15 | Mcnamara, Iain | Norfolk and Norwich University Hospital NHS Trust (United Kingdom) |
| 16 | Escudero-Sánchez, Rosa | Hospital Ramon y Cajal (Spain) |
| 17 | Arvieux, Cedric | Centre Hospitalier Universitaire de Rennes (France) |
| 18 | Batailler, Cecile | Hopital de la Croix-Rousse (France) |
| 19 | Dauchy, Frédéric Antoine | CHU Hôpitaux de Bordeaux (France) |
| 20 | Liu, Wai Yan | Catharina Hospital (Netherlands) |
| 21 | Lora-Tamayo, Jaime | Hospital Universitario 12 de Octubre (Spain) |
| 22 | Praena, Julia | Hospital Universitario Virgen del Rocío (Spain) |
| 23 | Ustianowski, Andrew | North Manchester General Hospital (United Kingdom) |
| 24 | Cinconze, Elisa | GlaxoSmithKline SpA (Italy) |
| 25 | Pellegrini, Michele | GlaxoSmithKline SpA (Italy) |
| 26 | Bagnoli, Fabio | GlaxoSmithKline SpA (Italy) |
| 27 | Rodríguez-Baño, Jesús | Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (Spain) |
| 28 | Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (Spain) | |
| # | Autoría grupal | Afiliación |
| 1 | ARTHR-IS group | Sin datos () |
